glp-1 medication common side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Part 2 of a 3-Part

Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats

A winning GLP-1 pharma marketing strategy embraces transparency

Plaintiffs allege that AstraZeneca failed to adequately warn patients and prescribing physicians about the potential risks, despite growing concerns within the medical community and clinical trial data suggesting dangers

While both medications share a primary mechanism of action, their tolerability profiles show distinct variations in clinical settings

**In a consumer study of 109 women after 28 days